Cargando…
Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”
Non-pharmaceutical interventions (NPI) for infectious diseases such as COVID-19 are particularly challenging given the complexities of what is both practical and ethical to randomize. We are often faced with the difficult decision between having weak trials or not having a trial at all. In a recent...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572532/ https://www.ncbi.nlm.nih.gov/pubmed/34743755 http://dx.doi.org/10.1186/s13063-021-05755-y |